Trial intelligence / Profile preview

Pre-induction Norepinephrine in Septic Patients Undergoing Surgery

NCT07869693Not yet recruiting

Sponsor
Assiut University
Start
Oct 2026
Primary completion
Oct 2027
01

Overview

Randomised, double-blind trial of norepinephrine in sepsis and hypotension (2 arms), sponsored by Assiut University. Primary endpoint: Incidence of post-induction hypotension. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

norepinephrine
03

Conditions

sepsishypotension

Beyond the preview

Go deeper on NCT07869693.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07869693.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call